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A cluster of sporotrichosis cases occurred in the Bus-
selton-Margaret River region of Western Australia from 2000 
to 2003. Epidemiologic investigation and mycologic culture 
for Sporothrix schenckii implicated hay initially distributed 
through a commercial hay supplier as the source of the out-
break. Declining infection rates have occurred after various 
community measures were instigated.
S
porotrichosis is an infection caused by the fungal spe-
cies Sporothrix schenckii. It predominantly causes sub-
acute to chronic subcutaneous infection, which occurs when 
the fungus enters small breaks in the skin (1). S. schenckii 
is widely found on organic material in the environment 
such as sphagnum moss, fruits, and plants. Human cases 
have been reported from intermediate hosts; cats were the 
source of an outbreak in Rio de Janeiro (1–3). Outbreaks in 
Australia and other countries have been previously linked 
to contact with hay (4,5).
In Western Australia, sporadic cases have occurred 
for many years in the southwest, particularly in the wheat-
growing areas (Figure 1), but in the year 2000 an increase 
in the number of cases of sporotrichosis was noted (6). 
Forty-one microbiologically conﬁ  rmed human cases were 
reported from 2000 to 2003 compared with 8 cases from 
1997 to 1999 at the PathWest Laboratory at QEII Medical 
Centre, which has branches throughout metropolitan and 
regional Western Australia. A review of these cases found 
that 22 cases were from the Busselton-Margaret River 
(BMR) region of Western Australia, where no cases had 
previously been recorded.
The Study
An epidemiologic study was begun in 2003 to deter-
mine the nature and source of the infection. Pathology labo-
ratories and general practitioners in the southwest region of 
Western Australia were contacted to ascertain patients with 
cases of sporotrichosis, deﬁ  ned as clinical evidence of dis-
ease supported by microbiologic conﬁ  rmation. Telephone 
interviews, which included questions on possible sources 
of infection, were conducted with all identiﬁ  ed patients. 
The epidemiologic study (Table 1) discovered 11 pa-
tients with a microbiologic diagnosis of sporotrichosis from 
July 2003 to July 2004 in the southwest region. All lived in 
the BMR region except for 2 (patients 3 and 5).
Nine of the 11 case-patients had contact with hay pre-
ceding the development of sporotrichosis; 8 had bought the 
hay from 1 of 2 commercial suppliers located in the town-
ship of Margaret River (outlet 1 and outlet 2). The remain-
ing patient had contact with hay grown on his property. 
Seven of the 9 persons with cases linked to hay exposure 
had used the hay for domestic gardening; the other 2 pa-
tients were exposed to hay used for commercial farming. 
Patients 10 and 11 were children who played together in 
hay purchased from outlet 1 before the onset of symptoms 
of sporotrichosis. Patients 1 and 3 had no documented hay 
exposure; sporotrichosis developed after a camping trip 
and after gardening, respectively.
Nine case-patients were initially treated with oral 
antimicrobial agents for a presumed bacterial infection. 
Because of a lack of clinical response, wound swabs or 
biopsy specimens were obtained. Sporotrichosis was sub-
sequently diagnosed, and antifungal therapy was then be-
gun. Four patients required inpatient treatment for 1 of 
several reasons: initially to receive intravenous antimicro-
bial agents before the diagnosis, to undergo debridement 
surgery and biopsy, or to treat complications related to 
Figure 1. Wheat-growing region and Busselton-Margaret River 
region of Western Australia.
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therapy. Ten of the 11 patients received oral itraconazole; 
1 of these patients also received a saturated solution of 
potassium iodide, and 1 patient ceased oral antifungal 
therapy because of severe side effects. One of the 11 re-
ceived only a naturopathic remedy.
When hay was implicated as a likely source, local 
environmental health ofﬁ   cers visited commercial hay 
outlets in the area to assess procurement, storage, and 
distribution practices. Fifty hay samples were collected 
from around the BMR region for mycologic culture. Six-
teen samples were from properties associated with 6 of 
the cases, 9 from the 2 commercial hay outlets, 7 from 
a farm that supplied hay to a commercial outlet, and 18 
from other properties in the BMR region not associated 
with the outbreak (control samples).
Mycologic culture for organisms from the Ophios-
toma–Sporothrix complex was performed on a portion of 
each hay sample. Isolates were examined for morphologic 
features and analyzed by pulsed-ﬁ  eld gel electrophoresis 
(PFGE) (7). Sequencing the ITS1 region with universal 
primers ITS1 and ITS2 and the ITS2 region with univer-
sal primers ITS3 and ITS4 was performed with Applied 
Biosystems BigDye Terminator v3.1 Cycle Sequencing 
reagent using the Applied Biosystems Prism 3100 Avant 
Genetic Analyzer (Foster City, CA, USA). Using ITS se-
quencing, de Beer et al. (8) distinguished clinical strains of 
S. schenckii from environmental strains.
Isolates positive for the clinical group of S. schenckii 
showed morphologic features of conidia that are predomi-
nantly oval and display sleeves of dematiaceous conidia 
along the hyphae. When BLAST software (www.ncbi.nlm.
nih.gov/blast) was used, these isolates had ITS2 sequences 
that conform to the clinical group noted by de Beer et al. 
(8). They differ from Western Australian environmental 
isolates of the Opiostoma–Sporothrix complex obtained in 
this study and clinical S. schenckii isolates from the eastern 
states of Australia in their morphologic features, PFGE pat-
terns (7), and ITS2 sequences (data not shown).
Of the 6 case-patient–related properties from which 
environmental samples were taken (Table 2), 3 had a single 
sample that was culture positive for S. schenckii (clinical 
strain). Each of these 3 patients had purchased hay from 
the same commercial hay outlet (outlet 1). One of the hay 
samples from outlet 1 was also culturally positive for S. 
schenckii clinical group. These 4 isolates had identical 
ITS2 sequences and morphologic features that were similar 
to all our patient isolates available for testing (the patient 5 
isolate was not available). S. schenckii (clinical strain) was 
not isolated from any of the control hay samples, although 
other members of the Opiostoma–Sporothrix complex were 
isolated in many environmental samples.
Table 1. Sporotrichosis cases in Western Australia, July 2003–July 2004 
Patient
no. Sex Age, y 
Area of 
residence
Pre-
existing
cuts
Onset of 
symptoms, 
mo/y 
Duration of 
disease, mo
Antifungal
treatment
Suspected
exposure*
GenBank
accession no.
1 F 57 BMR† Present 7/03 6 Surgery, oral 
traconazole,
oral K‡ 
Camping trip in 
a different 
region of 
Australia 
EF589115
2 M 48 BMR Present 10/03 5 Oral
traconazole
Hay (2)  EF589117
3 M 68 Greenbushes Present 11/03 4 Oral
traconazole
Gardening EF589116
4 F 39 BMR Present 12/03 4 Oral
traconazole
Hay (1)  EF589119
5 M 65 Collie Present 12/03 4 Oral 
traconazole
Hay (own 
supply)
Not available 
6 M 56 BMR Absent 12/03 4 Oral
traconazole
Hay (1)  EF589121
7 F 69 BMR Absent 1/04 2 Oral
traconazole
Hay (1)  EF589118
8 M 66 BMR Absent 1/04 3.5 Oral
traconazole
Hay (2)  EF589120
9 M 10 BMR Present 2/04 2 Surgery, oral 
traconazole
Hay (1)  EF589122
10 F 8 BMR Present 7/04 5 Oral
traconazole
Hay (1)  EF589124
11 F 3 BMR Present 7/04 5 Naturopathic 
treatment
Hay (1)  EF589123
*1 and 2 refer to outlet 1 and 2, respectively. 
†Busselton-Margaret River region. 
‡Saturated solution of potassium iodide. DISPATCHES
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Conclusions
The epidemiologic aspect of our study implicated con-
taminated hay as the source of an outbreak of sporotricho-
sis in the BMR region. Exposure was documented for 9 of 
the 11 case-patients. Most patients described contact with 
hay during gardening. Eight patients had contact with hay 
purchased at commercial suppliers in the Margaret River 
region.
Mycologic culture of hay samples conﬁ  rmed that the 
hay was a possible source of infection. Half of the case-re-
lated properties tested were culture positive for the clinical 
strain of S. schenckii, as was a sample from a commercial 
hay supplier that had supplied hay to these properties. None 
of the control samples or samples from a farm that supplied 
hay to this hay supplier showed S. schenckii (clinical strain) 
on mycologic culture.
All Western Australia clinical isolates tested—includ-
ing the BMR outbreak isolates, the isolates from the hay 
supplier, and 3 case-related hay samples—are indistin-
guishable by ITS2 sequencing and PFGE. These isolates 
differ from the environmental isolates of the Ophiostoma–
Sporothrix complex tested from our survey and from east-
ern states’ clinical isolates. Therefore, the epidemiological-
ly implicated hay from the commercial hay suppliers was 
considered the likely source of the regional outbreak.
This ﬁ  nding prompted intervention in the community. 
Commercial hay suppliers cooperated by destroying any 
moldy hay on their properties and storing hay awaiting sale 
on rubber matting under cover. Information about the diag-
nosis and management of the infection was distributed to 
general practitioners in the area, and general information 
was distributed to the community through various sources 
such as community newspapers. Since the initial outbreak 
of sporotrichosis in the BMR region, the infection rate has 
decreased (Figure 2). Further distribution of the organism 
by hay suppliers across the region appears to have ceased 
with the introduction of infection control measures.
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